A comprehensive and authoritative research study by Swiss scientists has offered an unambiguous endorsement of the evidence base for homeopathy as a clinically effective system of medicine.*
Their report, part of a Swiss government evaluation of complementary and alternative medicines, gives a massive boost to the growing body of research underpinning the therapeutic effects of homeopathic medicine.
The Society’s research consultant Rachel Roberts said the report also dismissed the claims of the only major systematic review ever to conclude that homeopathy’s effects are due to placebo, the controversial Shang meta-analysis, published in the Lancet in 2005 and heralded as “the end of homeopathy”.
Even though that study attracted criticism from international researchers due to its poor quality, both in terms of the methodology used and how the study was reported, it has been widely quoted by anti homeopathy campaigners as “proof’ that homeopathy is placebo.
Rachel, who is also the chief executive of the Homeopathy Research Institute, said: “This is great news for scientists who are committed to objective and accurate reporting of homeopathy research, as well as for the six million people in the UK who choose to use homeopathy as part of their healthcare.
“For too long anti-homeopathy campaigners have got away with using this flawed paper to unjustly damage the credibility of homeopathy and put pressure on decision-makers to cut homeopathy services. Being able to draw a line under the issue of the Shang paper will allow us to return to a more open, rational debate about homeopathy and its evidence base.”
The authors of the 234-page report, known as the Swiss Health Technology Assessment (HTA), exhaustively reviewed the clinical research in homeopathy (both systematic reviews and the original clinical studies). It includes a summary of 22 systematic reviews of clinical trials in specific medical conditions, 20 of which show a positive direction of evidence for homeopathy (with five of those 20 showing clear evidence of effectiveness).
The report also concluded that there was sufficient supporting evidence for the pre-clinical (experimental) effects of homeopathy and that, when compared to conventional therapies, it offers a safe and cost-effective treatment.
Alex Tournier, executive director of the Homeopathy Research Institute, said: “With the publication of the English translation of the HTA report, we hope that the debate will finally move from the question, ‘does homeopathy work?’ to the more pressing questions of ‘how does homeopathy work?’ and ‘what conditions can homeopathy treat effectively an